Literature DB >> 21503969

TCERG1 inhibits C/EBPα through a mechanism that does not involve sequestration of C/EBPα at pericentromeric heterochromatin.

Banafsheh Moazed1, Shanna L Banman, Grey A Wilkinson, William J Roesler.   

Abstract

Transcriptional elongation regulator 1 (TCERG1) is a nuclear protein that participates in multiple events that include regulating the elongation of RNA polymerase II and coordinating transcription and pre-mRNA processing. More recently, we showed that TCERG1 is also a specific inhibitor of the transcription factor CCAAT enhancer binding protein α (C/EBPα). Interestingly, the inhibition of C/EBPα by TCERG1 is associated with the relocalization of TCERG1 from the nuclear speckle compartment to the pericentromeric regions where C/EBPα resides. In the present study, we examined additional aspects of C/EBPα-induced redistribution of TCERG1. Using several mutants of C/EBPα, we showed that C/EBPα does not need to be transcriptionally competent or have anti-proliferative activity to induce TCERG1 relocalization. Moreover, our results show that C/EBPα does not need to be localized to the pericentromeric region in order to relocalize TCERG1. This conclusion was illustrated through the use of a V296A mutant of C/EBPα, which is incapable of binding to the pericentromeric regions of heterochromatin and thus takes on a dispersed appearance in the nucleus. This mutant retained the ability to redistribute TCERG1, however in this case the redistribution was from the nuclear speckle pattern to the dispersed phenotype of C/EBPα V296A. Moreover, we showed that TCERG1 was still able to inhibit the activity of the V296A mutant. While we previously hypothesized that TCERG1 might inhibit C/EBPα by keeping it sequestered at the pericentromeric regions, our new findings indicate that TCERG1 can inhibit C/EBPα activity regardless of the latter's location in the nucleus.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21503969     DOI: 10.1002/jcb.23154

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  2 in total

1.  Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation.

Authors:  Deborah L Diamond; Alexei L Krasnoselsky; Kristin E Burnum; Matthew E Monroe; Bobbie-Jo Webb-Robertson; Jason E McDermott; Matthew M Yeh; Jose Felipe Golib Dzib; Nathan Susnow; Susan Strom; Sean C Proll; Sarah E Belisle; David E Purdy; Angela L Rasmussen; Kathie-Anne Walters; Jon M Jacobs; Marina A Gritsenko; David G Camp; Renuka Bhattacharya; James D Perkins; Robert L Carithers; Iris W Liou; Anne M Larson; Arndt Benecke; Katrina M Waters; Richard D Smith; Michael G Katze
Journal:  Hepatology       Date:  2012-04-24       Impact factor: 17.425

2.  DAF-16 and TCER-1 Facilitate Adaptation to Germline Loss by Restoring Lipid Homeostasis and Repressing Reproductive Physiology in C. elegans.

Authors:  Francis Raj Gandhi Amrit; Elizabeth Marie Steenkiste; Ramesh Ratnappan; Shaw-Wen Chen; T Brooke McClendon; Dennis Kostka; Judith Yanowitz; Carissa Perez Olsen; Arjumand Ghazi
Journal:  PLoS Genet       Date:  2016-02-10       Impact factor: 5.917

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.